Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 10.03 CAD 0.3%
Market Cap: 247.4m CAD
Have any thoughts about
Profound Medical Corp?
Write Note

Profound Medical Corp
Investor Relations

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Arun Swarup Menawat MBA, Ph.D.
Chairman of the Board & CEO
No Bio Available
Dr. Mathieu Burtnyk Ph.D.
President
No Bio Available
Mr. Rashed Dewan
Chief Financial Officer
No Bio Available
Mr. Stephen Kilmer
Investor Relations
No Bio Available
Mr. Thomas Tamberrino MBA
Chief Commercial Officer
No Bio Available
Mr. Matthew Sobczyk C.A., CPA
Assistant Corporate Controller
No Bio Available
Mr. Levant Tinaz
Software Developer
No Bio Available

Contacts

Address
ONTARIO
Mississauga
2400 Skymark Ave Unit 6
Contacts